Coronary stent strut fracture after drug-eluting stent implantation: a newly recognized complication

Int J Cardiol. 2009 Feb 6;132(1):121-2. doi: 10.1016/j.ijcard.2007.07.011. Epub 2007 Aug 10.

Abstract

Stent strut fracture (SSF) after drug-eluting stent (DES) implantation may be an important complication after DES implantation particularly in patients undergoing sirolimus eluting stent implantation. Since SSF is a highly relevant adverse event which can result in in-stent restenosis and thrombosis, we believe that DES with flexible stent platform or biodegradable DES may be needed to prevent this potential catastrophic complication.

Publication types

  • Comment
  • Letter

MeSH terms

  • Coronary Restenosis / etiology*
  • Coronary Restenosis / prevention & control
  • Drug-Eluting Stents / adverse effects*
  • Drug-Eluting Stents / classification
  • Drug-Eluting Stents / standards
  • Equipment Failure
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Incidence
  • Risk Factors
  • Sirolimus / administration & dosage
  • Thrombosis / etiology*
  • Thrombosis / prevention & control
  • Treatment Failure

Substances

  • Immunosuppressive Agents
  • Sirolimus